Novartis to limit M&A spend to 5 of market value

Novartis to limit M&A spend to 5% of market value

23:00 EDT 8 Apr 2019 | Financial Times

Chief Vas Narasimhan looks to ‘drive more value for shareholders’ with focused deals

Original Article: Novartis to limit M&A spend to 5% of market value

More From BioPortfolio on "Novartis to limit M&A spend to 5% of market value"